James F. Tessmer is VP at LEXICON PHARMACEUTICALS, INC./DE (LXRX). They have made 4 open-market trades across 1 company since 2016, most recently 2021-03-15.
CIK 0001434095
1 open-market purchase totalling $11K since 2019, against 3 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| LXRX | 71,766 | $116K |
Shares reported on the most recent Form 4, priced at the 2021-03-16 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| LXRX | SELL | 2021-03-15 | 2021-03-16 | $6.91 | $234K | -8.7% | -19.1% | -25.6% |
| LXRX | BUY | 2019-08-02 | 2019-08-02 | $1.14 | $11K | +16.0% | +3.2% | +196.8% |
| LXRX | SELL | 2018-06-08 | 2018-06-12 | $12.91 | $129K | +4.9% | -4.2% | -16.0% |
| LXRX | SELL · 10b5-1 | 2016-06-06 | 2016-06-08 | $15.00 | $23K | -7.3% | +2.9% | -2.1% |
| LXRX | SELL | 2016-05-23 | 2016-05-23 | $13.00 | $78K | +9.8% | +0.2% | +16.8% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.